BioNTech and Pfizer and said their vaccine is highly effective among children in the 5-11-year age group. Follow DW for the latest.

After testing on more than 800,000 children in Malawi, Ghana and Kenya, the WHO has recommended the use of a vaccine against malaria, a disease that kills nearly 400,000 people every year, mostly children under five. The jab is effective against one of the parasites that transmits the disease and reduces the risk of severe cases by 30 percent, which is enough to save tens of thousands of lives. Associated with other methods, it could drastically reduce the number of sick people each year. Could it even contain the epidemic? Our correspondents report.

Younger people have a higher risk of heart inflammation with a Moderna shot, the country's vaccine advisory committee has said. It also advises on the BioNTech-Pfizer vaccine to all pregnant women.

German Free Democrat politician Moritz Körner said that the pair have saved "millions of lives." The euro is set to be redesigned over the coming years.

More than a million people worldwide die each year from infections linked to microbes resistant to antibiotics, a new study has found. Researchers describe the threat as "one of the greatest challenges facing humanity."

German pharmaceutical company BioNTech has begun construction of an COVID-19 vaccine plant in Rwanda. When completed, it will be the first mRNA vaccine plant in Africa.

The two German vaccine competitors are heading to court over a legal dispute concerning BioNTech's coronavirus vaccine. CureVac has called for "fair compensation."

Kenyan mother Rebecca Adhiambo Kwanya needed no convincing to take part in a pilot programme for the world’s first vaccine. Her older son, four-year-old Betrun, had frequent bouts of malaria since birth, unlike her younger son, 18-month-old Bradley, who was vaccinated in the pilot program.

Scientists in Oxford, UK, say trials for a new malaria vaccine show it could have a "major impact." They hope to start producing doses by 2023.

Researchers have linked an invasive mosquito to recent malaria outbreaks. The species thrives in urban areas and threatens to undo progress in eradicating the disease

Ghana is expanding its national malaria vaccine immunization program to ensure that the shots reach thousands of children at high risk of malaria. The program is coordinated by the World Health Organization with support from NGOs and other stakeholders.

A keenly-watched malaria vaccine from Oxford University has secured its first approval, in Ghana, as the African country ramps up efforts to combat the mosquito-borne disease that kills a child every minute.